White P G, Hayward M W, Cooper T
Department of Radiology, University Hospital of Wales, Heath Park, Cardiff, UK.
Nucl Med Commun. 1991 Apr;12(4):349-52.
A survey of radiologists and nuclear physicians in 360 hospitals in the UK was undertaken to assess the current use of pulmonary ventilation agents. Replies were received from 340 (94%) hospitals. Of these, 200 (59%) provided lung scanning. The agents used for ventilation studies were Tc-labelled aerosols (118, 59%), 81Krm (58, 29%), 133Xe (42, 21%) and 127Xe (4, 2%). Nine (4.5%) hospitals performed perfusion scintigraphy without providing ventilation imaging. Thirty-two (16%) hospitals used more than one agent for ventilation imaging.
对英国360家医院的放射科医生和核医学医生进行了一项调查，以评估肺部通气剂的当前使用情况。收到了340家（94%）医院的回复。其中，200家（59%）提供肺部扫描。用于通气研究的药剂有锝标记气雾剂（118家，59%）、81氪（58家，29%）、133氙（42家，21%）和127氙（4家，2%）。9家（4.5%）医院进行了灌注闪烁扫描但未提供通气成像。32家（16%）医院使用不止一种药剂进行通气成像。
